Is Gramicidin + Neomycin + Nystatin + Triamcinolone registered with the SFDA?

The SFDA human drug list (edition 4-2026, as published by the Council of Health Insurance) lists 6 valid registrations of Gramicidin + Neomycin + Nystatin + Triamcinolone, including Dermacom (100000,2.5,0.25,1 IU,mg,mg,mg, Cream, SAR 22.10); Dermacom (100000,2.5,0.25,1 IU,mg,mg,mg, Ointment, SAR 22.10); PANDERM CREAM (100000,0.25,0.1,0.025 IU,g,g,g, Cream, SAR 11.05); PANDERM SKIN OINTMENT (2.272,0.416,0.1,0.025 g,g,g,g, Ointment, SAR 11.05); ULTRADERM (19.763,3.709,1.0,0.25 mg/g,mg/g,mg/g,mg/g, Ointment, SAR 7.05).

Active substances

Gramicidin + Neomycin + Nystatin + Triamcinolone

SFDA 8
Health Canada 4

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade name	Strength	Form · route	Pack	Public price	Type	Company	Status
Dermacom	100000,2.5,0.25,1 IU,mg,mg,mg	Cream · Topical	1 Tube	SAR 22.10	Generic · Prescription	SPIMACO ADDWAEIH	Valid
Dermacom	100000,2.5,0.25,1 IU,mg,mg,mg	Ointment · Topical	1 Tube	SAR 22.10	Generic · Prescription	SPIMACO ADDWAEIH	Valid
PANDERM CREAM	100000,0.25,0.1,0.025 IU,g,g,g	Cream · Topical	1 Tube	SAR 11.05	Generic · Prescription	Gulf Pharmaceutical Industries (Julphar)	Valid
PANDERM SKIN OINTMENT	2.272,0.416,0.1,0.025 g,g,g,g	Ointment · Topical	1 Tube	SAR 11.05	Generic · Prescription	Gulf Pharmaceutical Industries (Julphar)	Valid
ULTRADERM	19.763,3.709,1.0,0.25 mg/g,mg/g,mg/g,mg/g	Ointment · Topical	1 Tube	SAR 7.05	Generic · Prescription	THE ARAB PHARMACEUTICAL MANUFACTURING PSC - Sult	Valid
ULTRADERM	19.763,3.709,1.0,0.25 mg/g,mg/g,mg/g,mg/g	Cream · Topical	1 Tube	SAR 7.45	Generic · Prescription	THE ARAB PHARMACEUTICAL MANUFACTURING PSC - Sult	Valid
KENACOMB CREAM		Cream · Topical	1 Tube	SAR 18.80	NCE · Prescription	SPIMACO ADDWAEIH	Withdrawn by MAH · Not Marketed
KENACOMB OINTMENT		Ointment · Topical	1 Tube	SAR 18.80	NCE · Prescription	SPIMACO ADDWAEIH	Withdrawn by MAH · Not Marketed

Indications — CHI Daman Drug Formulary

FUNGAL INFECTIONS OF THE GENITAL TRACT - CANDIDIASIS OF VULVA AND VAGINA & CANDIDIASIS OF OTHER UROGENITAL SITES

Canada Canada — marketed products (Health Canada)

Brand	DIN	Strength	Form · route	Company
TEVA-TRIACOMB	00550507	100000 UNIT / G; 1 MG / G; 2.5 MG / G; 0.25 MG / G	CREAM · TOPICAL	TEVA CANADA LIMITED
THERADERM CREAM	02022818	2.5 MG / G; 1 MG / G; 100000 UNIT / G; 0.25 MG / G	CREAM · TOPICAL	BIMEDA-MTC ANIMAL HEALTH INC
VIADERM KC CRM	00717002	2.5 MG / G; 100000 UNIT / G; 0.25 MG / G; 1 MG / G	CREAM · TOPICAL	TARO PHARMACEUTICALS INC
VIADERM KC ONT	00717029	1 MG / G; 2.5 MG / G; 0.25 MG / G; 100000 UNIT / G	OINTMENT · TOPICAL	TARO PHARMACEUTICALS INC

Components

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.